BNGO Insider Trading

Insider Ownership Percentage: 1.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Bionano Genomics Insider Trading History Chart

This chart shows the insider buying and selling history at Bionano Genomics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$50k$0$50kTotal Insider BuyingTotal Insider Selling

Bionano Genomics Share Price & Price History

Current Price: $3.32
Price Change: Price Decrease of -0.29 (-8.03%)
As of 03/13/2025 05:00 PM ET

This chart shows the closing price history over time for BNGO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
AprMayJunJulAugSepOctNovDecJanFebMar$3.32Closing price on 03/13/25:

Bionano Genomics Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Bionano Genomics (NASDAQ:BNGO)

11.35% of Bionano Genomics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BNGO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$2.90Mbought$117ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$20M-$10M$0$10M$20MTotal InflowsTotal Outflows
Bionano Genomics logo
Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.
Read More on Bionano Genomics

Today's Range

Now: $3.32
Low: $3.30
High: $3.73

50 Day Range

MA: $7.64
Low: $3.61
High: $19.00

52 Week Range

Now: $3.32
Low: $3.30
High: $72.60

Volume

56,545 shs

Average Volume

238,959 shs

Market Capitalization

$9.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.24

Who are the company insiders with the largest holdings of Bionano Genomics?

Bionano Genomics' top insider investors include:
  1. R Erik Holmlin (CEO)
  2. Christopher P Stewart (CFO)
  3. Hannah Mamuszka (Director)
Learn More about top insider investors at Bionano Genomics.

Who are the major institutional investors of Bionano Genomics?

Bionano Genomics' top institutional investors include:
  1. Geode Capital Management LLC — 51.16%
  2. Jane Street Group LLC — 21.05%
  3. Renaissance Technologies LLC — 8.12%
  4. XTX Topco Ltd — 8.07%
  5. Northern Trust Corp — 6.98%
  6. Carret Asset Management LLC — 6.10%
Learn More about top institutional investors of Bionano Genomics stock.

Which major investors are selling Bionano Genomics stock?

During the previous quarter, BNGO stock was sold by these institutional investors:
  1. Citadel Advisors LLC
  2. Northern Trust Corp
  3. Group One Trading LLC

Which major investors are buying Bionano Genomics stock?

During the last quarter, BNGO stock was purchased by institutional investors including:
  1. Jane Street Group LLC
  2. Renaissance Technologies LLC
  3. XTX Topco Ltd
  4. Geode Capital Management LLC
  5. Carret Asset Management LLC
In the last year, these company insiders have bought Bionano Genomics stock:
  1. R Erik Holmlin (CEO)
  2. Christopher P Stewart (CFO)
  3. Hannah Mamuszka (Director)
Learn More investors buying Bionano Genomics stock.